Switzerland Healthcare & Medical Tourism Market Size to Surpass USD 148.62 BN by 2034
The Switzerland healthcare & medical tourism market size was exhibited at USD 72.11 billion in 2024 and is projected to hit around USD 148.62 billion by 2034, growing at a CAGR of 7.5% during the forecast period 2025 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 77.52 Billion |
| Market Size by 2034 | USD 148.62 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 7.5% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | End-use, Service |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Key Companies Profiled | Klinik Hirslanden; Swiss Medica XXI Century S.A.; Biologic Aesthetic Dentalcare; Berit Klinik; Clinique de Genolier; Clinique de Montchoisi; Hirslanden Clinique Cecil; Private Clinic Mentalva; Rehabilitation Clinic Zihlschlacht; Grand Resort Bad Ragaz; Clinica Sant’Anna; The Waldhotel; Swiss Medical Network; The Swiss Leading Hospital; Privatklinik Hohenegg AG; Klinik Im Park; Private Clinic Meiringen; Hirslanden Klinik Aarau; Pyramide am See Clinic; Salem-Spital; Schmerzklinik Basel; Klinik Beau-Site; Clinique La Colline; SW!SS REHA; Berit Klinik; BESAS Bern Hospital Center for Geriatric Medicine; cereneo Schweiz AG; CLINIC BAD RAGAZ; LEUKERBAD CLINIC; Clinique de Maisonneuve; Clinique Valmont; Hochgebirgsklinik Davos; Hof Weissbad AG; Klinik Schloss Mammern; Oberwaid AG; Rehaklinik Dussnang AG; Salina Rehabilitation Clinic |
The increasing adoption of initiatives to promote medical tourism, along with the high quality of medical care, is expected to boost the growth of the market. The Switzerland healthcare industry has established a reputation for good and efficient healthcare services. Although there is a regional disparity in healthcare-related satisfaction among citizens, the overall scenario seems to be positive in the country. Moreover, the established healthcare system in the localities enables the health industry to focus on the incoming medical tourists.
Switzerland is one of the major medical tourism destinations, and efforts are being made to improve medical tourism services. Switzerland Tourism (ST) took the initiative to partner with hospitals and clinics, with a focus on the quality of infrastructure, medical expertise, and location in a relaxing environment and natural setting. In 2019, ST successfully partnered with 26 hospitals and clinics in the region, and with the help of its 33 regional offices worldwide, it offers its partners an opportunity to increase their visibility in foreign markets. Moreover, in 2020, ST launched its magazine and website, contributing to its marketing strategy and further plans to participate in various events in Russia, China, and Gulf countries to showcase Switzerland's health tourism facilities. Such activities have helped establish Switzerland as a medical tourist destination on the global platform.
Switzerland is home to numerous medical offices, hospitals, and wellness facilities that provide patient-centered care.H+ Swiss Hospitals is a leading association in Switzerland comprising both public and private hospitals, clinics, and institutions for special care. It has 263 hospitals, clinics, and institutes for special care, spread across 369 different locations.
Even though the cost of medical care is high compared to other European countries, Switzerland has always been a popular destination for medical tourism. This can be attributed to the well-established healthcare infrastructure with the presence of trained healthcare professionals, high-quality care, high patient privacy standards, and beautiful locations.
Access to technologically advanced medical devices, diagnostic procedures, and robot-assisted minimally invasive surgeries, the availability of luxurious facilities are the primary factors for patients visiting Switzerland for medical treatment. For example, Hirslanden Klinik Aarau provides surgical robotic procedure services for international patients. Innovations in surgical techniques can help in reducing the cost of medical treatment in Switzerland. As per the Organization for Economic Co-operation and Development (OECD), Switzerland has one of the longest durations of hospital stay. Technological advancements in minimally invasive surgeries can result in a significant reduction in length of stay and in-patient costs.
In terms of end-use, the public care segment held the largest revenue share of 73.7% in 2024. This is attributed to strong government support and increased healthcare spending. Medical tourists have given a major boost to the country’s medical tourism industry, and they prefer public centers as compared to private care providers. Initiatives by Switzerland Tourism such as business partnerships to support targeted marketing campaigns contribute to the increase in medical tourists.
The private care segment is anticipated to grow at the fastest CAGR of 8.1% during the forecast period. The presence of large private hospital groups with dozens of private clinics and hospitals at various sites with world-class healthcare facilities is favoring the demand for private hospitals in Switzerland. For instance, Hirslanden Private Hospital Group comprises 17 private hospitals across various locations in Switzerland. Similarly, the Swiss leading hospitals are a network of 18 private hospitals and 236 doctors across Switzerland. These hospitals are renowned for their medical expertise and quality among international patients. The growing network of these large hospitals by the establishment of more clinics and centers is fueling the growth of the private care segment.
Medical tourists coming from Gulf countries have given a major boost to the country’s medical tourism industry. Switzerland Tourism is taking active steps and measures such as collaboration with clinics and sponsorships to attract medical tourists to Switzerland. For instance, in 2020, Switzerland Tourism generated USD 7.2 million through business partnerships to support targeted marketing campaigns. However, the high cost of medical care, high tariffs for surgical procedures, and increased out-of-pocket expenses are important factors restricting the segment growth.
In terms of service, the radiology segment held the largest revenue share of 25.0% in 2024. Among various techniques, Computed Tomography (CT) has observed an increase due to its application in minimally invasive surgeries, such as percutaneous biopsy and percutaneous abscess drainage, along with diagnostics. Health services are benefiting from the availability of innovative products in the market, thus increasing the efficiency of treatment.
The service segment faces certain challenges such as a shortage of local healthcare workers due to the inadequate supply of workforce from training institutes, difficulty in maintaining work-life balance due to overwork, and a continuous increase in demand for healthcare services. Specifically, a significant shortage of nurses in long-term care facilities is a concern, considering the continuously increasing geriatric population in the country.
The cardiovascular treatment segment is anticipated to register the fastest CAGR of 8.8% over the forecast period. Switzerland offers a wide range of cardiovascular treatment services, including diagnosis, prevention, and intervention for various cardiovascular conditions. Switzerland boasts of highly skilled healthcare professionals and renowned cardiovascular specialists who are trained in the latest techniques and advancements in cardiovascular care. The country's hospitals and clinics are equipped with state-of-the-art technology and facilities to provide cutting-edge treatments.
Switzerland has a reputation for delivering high-quality healthcare services, with a focus on patient safety, precision, and personalized care. The country consistently ranks among the top in global healthcare quality indices, assuring patients seeking services such as cardiovascular treatment, dental treatment, fertility, and gynecology treatment, pain management, and others.
The medical tourism industry in Switzerland is witnessing remarkable growth owing to the influx of international patients in the country for medical purposes. As the majority of private hospitals are located in Zurich, Geneva, Bern, Basel, and Lausanne, these regions receive the most medical tourists. Both private and public hospitals in the country have established their reputation for the quality of care.
According to the OECD, in Switzerland, 100% of the population is eligible for core healthcare services. Furthermore, there are 4.3 practicing physicians per 1,000 inhabitants, which is close to the OECD average, and 17.2 practicing nurses per 1,000 inhabitants, which is above the OECD average. Thus, the well-developed healthcare infrastructure and the growing popularity of Switzerland for medical tourism are anticipated to drive the market.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the Switzerland healthcare & medical tourism market
By End-use
By Service
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. End-use
1.1.2. Service
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. End-use outlook
2.2.2. Service outlook
2.2.3. Country outlook
2.3. Competitive Insights
Chapter 3. Switzerland Healthcare & Medical Tourism Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Switzerland Healthcare & Medical Tourism Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Switzerland Healthcare & Medical Tourism: End-use Estimates & Trend Analysis
4.1. Switzerland Healthcare & Medical Tourism Market: Key Takeaways
4.2. Switzerland Healthcare & Medical Tourism Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Private Care
4.3.1. Private care market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Public Care
4.4.1. Public care market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Switzerland Healthcare & Medical Tourism: Service Estimates & Trend Analysis
5.1. Switzerland Healthcare & Medical Tourism Market: Key Takeaways
5.2. Switzerland Healthcare & Medical Tourism Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Radiology
5.3.1. Radiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Orthopedics
5.4.1. Orthopedics market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Aesthetic Medicine
5.5.1. Aesthetic medicine market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Cardiovascular Treatment
5.6.1. Cardiovascular treatment market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Pain Management
5.7.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Fertility and Gynecology Treatment
5.8.1. Fertility and gynecology treatment market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Gastroenterology
5.9.1. Gastroenterology market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Dental Treatment
5.10.1. Dental treatment market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Others
5.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Klinik Hirslanden
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Swiss Medica XXI Century S.A.
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Biologic Aesthetic Dentalcare
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Berit Klinik
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Clinique de Genolier
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Clinique de Montchoisi
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Hirslanden Clinique Cecil
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Private Clinic Mentalva
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Rehabilitation Clinic Zihlschlacht
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Grand Resort Bad Ragaz
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Clinica Sant’Anna
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. The Waldhotel
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
6.2.13. Swiss Medical Network
6.2.13.1. Company overview
6.2.13.2. Financial performance
6.2.13.3. Product benchmarking
6.2.13.4. Strategic initiatives
6.2.14. The Swiss Leading Hospital
6.2.14.1. Company overview
6.2.14.2. Financial performance
6.2.14.3. Product benchmarking
6.2.14.4. Strategic initiatives
6.2.15. Privatklinik Hohenegg AG
6.2.15.1. Company overview
6.2.15.2. Financial performance
6.2.15.3. Product benchmarking
6.2.15.4. Strategic initiatives
6.2.16. Klinik Im Park
6.2.16.1. Company overview
6.2.16.2. Financial performance
6.2.16.3. Product benchmarking
6.2.16.4. Strategic initiatives
6.2.17. Private Clinic Meiringen
6.2.17.1. Company overview
6.2.17.2. Financial performance
6.2.17.3. Product benchmarking
6.2.17.4. Strategic initiatives
6.2.18. Hirslanden Klinik Aarau
6.2.18.1. Company overview
6.2.18.2. Financial performance
6.2.18.3. Product benchmarking
6.2.18.4. Strategic initiatives
6.2.19. Pyramide am See Clinic
6.2.19.1. Company overview
6.2.19.2. Financial performance
6.2.19.3. Product benchmarking
6.2.19.4. Strategic initiatives
6.2.20. Salem-Spital
6.2.20.1. Company overview
6.2.20.2. Financial performance
6.2.20.3. Product benchmarking
6.2.20.4. Strategic initiatives
6.2.21. Schmerzklinik Basel
6.2.21.1. Company overview
6.2.21.2. Financial performance
6.2.21.3. Product benchmarking
6.2.21.4. Strategic initiatives
6.2.22. Klinik Beau-Site
6.2.22.1. Company overview
6.2.22.2. Financial performance
6.2.22.3. Product benchmarking
6.2.22.4. Strategic initiatives
6.2.23. Colline SW!SS REHA
6.2.23.1. Company overview
6.2.23.2. Financial performance
6.2.23.3. Product benchmarking
6.2.23.4. Strategic initiatives
6.2.24. Berit Clinic
6.2.24.1. Company overview
6.2.24.2. Financial performance
6.2.24.3. Product benchmarking
6.2.24.4. Strategic initiatives
6.2.25. Bern Hospital Center for Geriatric Medicine
6.2.25.1. Company overview
6.2.25.2. Financial performance
6.2.25.3. Product benchmarking
6.2.25.4. Strategic initiatives
6.2.26. cereneo Schweiz AG
6.2.26.1. Company overview
6.2.26.2. Financial performance
6.2.26.3. Product benchmarking
6.2.26.4. Strategic initiatives
6.2.27. CLINIC BAD RAGAZ
6.2.27.1. Company overview
6.2.27.2. Financial performance
6.2.27.3. Product benchmarking
6.2.27.4. Strategic initiatives
6.2.28. LEUKERBAD CLINIC
6.2.28.1. Company overview
6.2.28.2. Financial performance
6.2.28.3. Product benchmarking
6.2.28.4. Strategic initiatives
6.2.29. Clinique de Maisonneuve
6.2.29.1. Company overview
6.2.29.2. Financial performance
6.2.29.3. Product benchmarking
6.2.29.4. Strategic initiatives
6.2.30. Clinique Valmont
6.2.30.1. Company overview
6.2.30.2. Financial performance
6.2.30.3. Product benchmarking
6.2.30.4. Strategic initiatives
6.2.31. Hochgebirgsklinik Davos
6.2.31.1. Company overview
6.2.31.2. Financial performance
6.2.31.3. Product benchmarking
6.2.31.4. Strategic initiatives
6.2.32. Hof Weissbad AG
6.2.32.1. Company overview
6.2.32.2. Financial performance
6.2.32.3. Product benchmarking
6.2.32.4. Strategic initiatives
6.2.33. Klinik Schloss Mammern
6.2.33.1. Company overview
6.2.33.2. Financial performance
6.2.33.3. Product benchmarking
6.2.33.4. Strategic initiatives
6.2.34. Oberwaid AG
6.2.34.1. Company overview
6.2.34.2. Financial performance
6.2.34.3. Product benchmarking
6.2.34.4. Strategic initiatives
6.2.35. Rehaklinik Dussnang AG
6.2.35.1. Company overview
6.2.35.2. Financial performance
6.2.35.3. Product benchmarking
6.2.35.4. Strategic initiatives
6.2.36. Salina Rehabilitation Clinic
6.2.36.1. Company overview
6.2.36.2. Financial performance
6.2.36.3. Product benchmarking
6.2.36.4. Strategic initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers